Chronicity
Chronicity was a healthcare service provider for treating fibromyalgia, chronic fatigue syndrome, ADD/ADHD, and learning disabilities
About Chronicity
Chronicity Inc. is a health technology company focused on providing solutions for chronic disease management. The company operates in the digital health sector, specifically targeting the needs of multispecialty clinics and healthcare providers who manage patients with long-term health conditions.
The core of Chronicity's offering is a platform that integrates artificial intelligence to streamline clinical workflows. It specializes in translating clinical conversations into structured SOAP notes automatically, aiming to significantly reduce the administrative burden on physicians. This allows clinicians to dedicate more time to direct patient care. The platform is designed to be HIPAA-compliant and integrates with existing Electronic Medical Record (EMR) systems, enhancing documentation without adding cumbersome tools. The service initially focuses on cardiology, with plans to expand to other specialties.
In addition to AI-powered note generation, Chronicity incorporates Remote Patient Monitoring (RPM) for chronic care. This functionality enables the monitoring of patient vital signs for conditions such as diabetes, congestive heart failure, weight management, and hypertension. The system utilizes FDA-cleared devices like 4G cellular weight scales to collect data, which is then reviewed by a dedicated clinician team. This allows for proactive interventions and personalized care adjustments. The business model appears to be service-based, with billing facilitated through CPT codes for the monitoring services provided. The company targets small to mid-sized multispecialty clinics, including primary care physicians, cardiologists, endocrinologists, and nephrologists, among others.
Source: Dealroom company dataAt a glance
- Founded
- 2006
- Headquarters
- Addison, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Chrysalis Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chronicity on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chronicity on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.